Treatment response for acute depression is not associated with number of previous episodes: Lack of evidence for a clinical staging model for major depressive disorder

Development of a Rating Scale for Primary Depressive Illness

Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410 · see citing works

Bipolar Disorder

Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515 · see citing works

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140 · see citing works

Clinical Staging of Psychiatric Disorders: A Heuristic Framework for Choosing Earlier, Safer and more Effective Interventions

McGorry, P. D., Hickie, I. B., Yung, A. R., Pantelis, C., & Jackson, H. J. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01860.x · Cited by 919 · see citing works

Time to Recovery, Chronicity, and Levels of Psychopathology in Major Depression: A 5-Year Prospective Follow-up of 431 Subjects

Keller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864 · see citing works

Multiple recurrences of major depressive disorder

Solomon, D. A., Keller, M. B., Leon, A. C., Mueller, T. I., Lavori, P. W., Shea, M. T., Coryell, W., Warshaw, M., Turvey, C., Maser, J. D., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.229 · Cited by 835 · see citing works

Stressful Life Events and Previous Episodes in the Etiology of Major Depression in Women: An Evaluation of the “Kindling” Hypothesis

Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1243 · Cited by 721 · see citing works

Population-based study of first onset and chronicity in major depressive disorder

Eaton, W. W., Shao, H., Nestadt, G., Lee, B. H., Bienvenu, O. J., & Zandi, P. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.513 · Cited by 612 · see citing works

Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder

Judd, L. L., Akiskal, H. S., Zeller, P. J., Paulus, M., Leon, A. C., Maser, J. D., Endicott, J., Coryell, W., Kunovac, J. L., Mueller, T. I., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.375 · Cited by 593 · see citing works

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529 · see citing works

Mapping the depressed brain: A meta-analysis of structural and functional alterations in major depressive disorder

Sacher, J., Neumann, J., Fünfstück, T., Soliman, A., Villringer, A., & Schroeter, M. L. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.001 · Cited by 410 · see citing works

Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial

Detke, M. J., Lu, Y., Goldstein, D. J., Hayes, J. R., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0407 · Cited by 384 · see citing works

Duloxetine in the Treatment of Major Depressive Disorder: A Double-Blind Clinical Trial

Goldstein, D. J., Mallinckrodt, C., Lu, Y., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0309 · Cited by 334 · see citing works

Duloxetine in the Treatment of Depression: A Double-Blind Placebo-Controlled Comparison With Paroxetine

Goldstein, D. J., Lu, Y., Detke, M. J., Wiltse, C., Mallinckrodt, C., & Demitrack, M. A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000132448.65972.d9 · Cited by 314 · see citing works

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.002 · Cited by 283 · see citing works

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

Detke, M. J., Lu, Y., GOLDSTEIN, D. J., McNamara, R. K., & Demitrack, M. A. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00060-2 · Cited by 278 · see citing works

Clinical Staging: A Heuristic and Practical Strategy for New Research and Better Health and Social Outcomes for Psychotic and Related Mood Disorders

McGorry, P. D., Nelson, B., Goldstone, S. D., & Yung, A. R. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500803 · Cited by 275 · see citing works

Setting the stage: from prodrome to treatment resistance in bipolar disorder

Berk, M., Conus, P., Lucas, N., Hallam, K. T., Malhi, G. S., Dodd, S., Yatham, L. N., Yung, A. R., & McGorry, P. D. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00484.x · Cited by 239 · see citing works

Staging of Mental Disorders: Systematic Review

Cosci, F., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000342243 · Cited by 235 · see citing works

Moving towards a population health approach to the primary prevention of common mental disorders

Jacka, F. N., Mykletun, A., & Berk, M. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-149 · Cited by 235 · see citing works

RECOVERY, CHRONICITY, AND LEVELS OF PSYCHOPATHOLOGY IN MAJOR DEPRESSION

Mueller, T. I., & Leon, A. C. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70275-6 · Cited by 234 · see citing works

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

Berk, M., Brnabic, A. J. M., Dodd, S., Kelin, K., Tohen, M. F., Malhi, G. S., Berk, L., Conus, P., & McGorry, P. D. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00889.x · Cited by 187 · see citing works

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder

Brannan, S. K., Mallinckrodt, C. H., Brown, E. B., Wohlreich, M. M., Watkin, J. G., & Schatzberg, A. F. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.04.011 · Cited by 179 · see citing works

Advances in Protein Chemistry and Structural Biology

(2021) · Advances in protein chemistry and structural biology · doi:10.1016/s1876-1623(21)00003-1 · Cited by 174 · see citing works

Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort

KENNEDY, N., ABBOTT, R., & PAYKEL, E. S. (2003) · Psychological Medicine · doi:10.1017/s003329170300744x · Cited by 165 · see citing works

Progressive Brain Changes in Children and Adolescents With First-Episode Psychosis

Arango, C. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.150 · Cited by 147 · see citing works

Longitudinal Course of Bipolar I Disorder

Solomon, D. A., Leon, A. C., Coryell, W. H., Endicott, J., Li, C., Fiedorowicz, J. G., Boyken, L., & Keller, M. B. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.15 · Cited by 145 · see citing works

Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation

Asami, T., Sylvain Bouix, A., Whitford, T. J., Shenton, M. E., Salisbury, D. F., & McCarley, R. W. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.066 · Cited by 143 · see citing works

Twenty‐five‐year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study

Fichter, M. M., Quadflieg, N., Fischer, U. C., & Kohlboeck, G. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01512.x · Cited by 136 · see citing works

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

Nierenberg, A. A., Greist, J. H., Mallinckrodt, C. H., Prakash, A., Sambunaris, A., Tollefson, G. D., & Wohlreich, M. M. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167453 · Cited by 131 · see citing works

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

David, P., Wang, F., Mallinckrodt, C. H., Walker, D. J., & Detke, M. J. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.03.004 · Cited by 128 · see citing works

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

Singh, A., Bousman, C., Ng, C. H., Byron, K., & Berk, M. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.115 · Cited by 110 · see citing works

Early life adversity is associated with brain changes in subjects at family risk for depression

Carballedo, A., Lisiecka, D., Fagan, A., Saleh, K., Ferguson, Y., Connolly, G., Meaney, J., & Frodl, T. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.661079 · Cited by 107 · see citing works

Progressive neurostructural changes in adolescent and adult patients with bipolar disorder

Lisy, M. E., Jarvis, K., DelBello, M. P., Mills, N. P., Weber, W. A., Fleck, D. E., Strakowski, S. M., & Adler, C. M. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00927.x · Cited by 103 · see citing works

Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Magalhães, P. V. D. S., Dodd, S., Nierenberg, A. A., & Berk, M. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412460593 · Cited by 98 · see citing works

From neuroprogression to neuroprotection: implications for clinical care.

Berk, M., Conus, P., Kapczinski, F. P., Andreazza, A. C., Yücel, M., Wood, S. J., Pantelis, C., Malhi, G. S., Dodd, S., Bechdolf, A., et al. (2010) · PubMed · Cited by 96 · see citing works

Basic symptoms in early psychotic and depressive disorders

Schultze‐Lutter, F., Ruhrmann, S., Picker, H., von Reventlow, H. G., Brockhaus‐Dumke, A., & Klosterkötter, J. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.51.s31 · Cited by 86 · see citing works

Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research

Eker, M. C., & Gönül, A. S. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902737998 · Cited by 76 · see citing works

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder

David, P., Pritchett, Y., Kajdasz, D. K., Bauer, M., Jain, R., Russell, J. M., Walker, D. J., Spencer, K. A., Froud, D. M., Raskin, J., et al. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.01.008 · Cited by 74 · see citing works

Pharmacogenetics of antidepressant response

Keers, R., & Aitchison, K. J. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.186 · Cited by 66 · see citing works

The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity: Duloxetine in elderly patients with depression

Wise, T. N., Wiltse, C. G., Iosifescu, D. V., Sheridan, M., Xu, J. Y., & Raskin, J. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01476.x · Cited by 62 · see citing works

Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research

Eker, M. C., & Gönül, A. S. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970902737998 · Cited by 59 · see citing works

Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive Disorder

Raskin, J., Wiltse, C. G., Dinkel, J. J., Walker, D. J., Desaiah, D., & Katona, C. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160738e · Cited by 58 · see citing works

Inflammation-Related Disorders in the Tryptophan Catabolite Pathway in Depression and Somatization

Anderson, G., Maes, M. H. J., & Berk, M. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00002-7 · Cited by 54 · see citing works

Once‐daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double‐blind, randomized, paroxetine‐controlled, non‐inferiority trial in China, Korea, Taiwan and Brazil

Lee, P., Shu, L., Xu, X., Wang, C., Lee, M. S., LIU, C., Hong, J. P., Ruschel, S. I., Raskin, J., Colman, S. A., et al. (2007) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01666.x · Cited by 50 · see citing works

Parental Bonding and Self-Esteem as Predictors of Severe Depressive Symptoms

Grotmol, K. S., Ekeberg, Ø., Finset, A., Gude, T., Moum, T., Vaglum, P., & Tyssen, R. (2010) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181c8189c · Cited by 41 · see citing works

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

Oakes, T. M. M., Myers, A. L., Marangell, L. B., AHL, J. S. B., Prakash, A., Thase, M. E., & Kornstein, S. G. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1262 · Cited by 36 · see citing works

Predictors of antidepressant response: A selective review

Dodd, S., & Berk, M. (2004) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500410005423 · Cited by 32 · see citing works

A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode

Martinez, J. M., Katon, W. J., Greist, J. H., Kroenke, K., Thase, M. E., Meyers, A. L., Edwards, S. E., Marangell, L. B., Shoemaker, S., & Swindle, R. W. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834ce11b · Cited by 30 · see citing works

Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder

Raskin, J., Xu, J., & Kajdasz, D. (2008) · International Psychogeriatrics · doi:10.1017/s1041610207005649 · Cited by 28 · see citing works

Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics

David, P., Kajdasz, D. K., Royer, M. G., Walker, D. J., & Raskin, J. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200609000-00007 · Cited by 16 · see citing works

Factors associated with reported childhood depressive symptoms at age 8 and later self-reported depressive symptoms among boys at age 18

Rønning, J. A., Haavisto, A., Nikolakaros, G., Helenius, H. Y. M., Tamminen, T., Moilanen, I. K., Kumpulainen, K., Piha, J., Almqvist, F., & Sourander, A. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0182-6 · Cited by 14 · see citing works

Preventive psychiatry: a blueprint for improving the mental health of young people

Fusar‐Poli, P., Correll, C. U., Arango, C., Berk, M., Patel, V., & Ioannidis, J. P. A. (2021) · World Psychiatry · doi:10.1002/wps.20869 · Cited by 497 · see citing works

Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications

Anderson, G., Berk, M., Dean, O. M., Moylan, S., & Maes, M. H. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0119-1 · Cited by 93 · see citing works

Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin

Berk, M., Mohebbi, M., Dean, O. M., Cotton, S., Chanen, A. M., Dodd, S., Ratheesh, A., Amminger, G. P., Phelan, M., Weller, A., et al. (2020) · BMC Medicine · doi:10.1186/s12916-019-1475-6 · Cited by 72 · see citing works

Prevalence of ADHD symptoms across clinical stages of major depressive disorder

Bron, T. I., Bijlenga, D., Verduijn, J., Penninx, B. W. J. H., Beekman, A. T. F., & Kooij, J. J. S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.053 · Cited by 68 · see citing works

Proton magnetic resonance spectroscopy of N-acetyl aspartate in first depressive episode and chronic major depressive disorder: A systematic review and meta-analysis

Saccaro, L. F., Tassone, M., Tozzi, F., & Rutigliano, G. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.150 · Cited by 42 · see citing works

Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions

Marshe, V. S., Islam, F., Maciukiewicz, M., Bousman, C., Eyre, H. A., Lavretsky, H., Mulsant, B. H., Reynolds, C. F., Lenze, E. J., & Müller, D. J. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.01.007 · Cited by 39 · see citing works

Between wellness, relapse, and remission: Stages of illness in anorexia nervosa

Steinglass, J. E., Glasofer, D. R., Dalack, M., & Attia, E. (2020) · International Journal of Eating Disorders · doi:10.1002/eat.23237 · Cited by 28 · see citing works

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials

Montgomery, S., Gommoll, C., Chen, C., & Greenberg, W. M. (2014) · CNS Spectrums · doi:10.1017/s1092852914000273 · Cited by 27 · see citing works

The progress in the field of clinical staging for mental disorders within the last decade: an updated systematic review

Clarke, S. L., Soons, N., Videler, A. C., van Alphen, S. P. J., Van, H. L., Dil, L., Pappijn, L., Corbeij, S., Broekhof, B., Chanen, A. M., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1473051 · Cited by 16 · see citing works

The clinical relevance of qualitatively distinct subtypes of depression

Kessing, L. V., & Bukh, J. D. (2017) · World Psychiatry · doi:10.1002/wps.20461 · Cited by 12 · see citing works

Does Early Improvement in Anxiety Symptoms in Patients with Major Depressive Disorder Affect Remission Rates? A Post-Hoc Analysis of Pooled Duloxetine Clinic Trials

Altın, M., Harada, E., Schacht, A., Berggren, L., Walker, D. J., & Dueñas, H. (2014) · Open Journal of Depression · doi:10.4236/ojd.2014.33015 · Cited by 8 · see citing works

Staging of depressive disorders: Relevance of resistance to treatment and residual symptoms

Reneses, B., Aguera-Ortiz, L., Sevilla-Llewellyn-Jones, J., Carrillo, A., Argudo, I., Regatero, M. J., López-Micó, C., Fuentes, M., & Palomo, T. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.07.022 · Cited by 7 · see citing works

The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD

Kornstein, S. G., Gommoll, C., Chen, C., & Kramer, K. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.058 · Cited by 6 · see citing works

Factors associated with placebo response in depression trials: A systematic review of published meta-analyses (1990–2017)

Schoemaker, J. H., Kilian, S., Emsley, R. A., & Vingerhoets, A. J. J. M. (2018) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2018.04.002 · Cited by 3 · see citing works

Effect of age on the response to serotonergic and noradrenergic antidepressants: A systematic review, meta-regression and individual participant data pooled analysis

Ossola, P., Gerra, M. L., Luviè, L., Piacente, A., Marchesi, C., Schoretsanitis, G., & Stewart, J. W. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.02.013 · Cited by 2 · see citing works

Impact of Pretreatment With Antidepressants on the Efficacy of Duloxetine in Terms of Mood Symptoms and Functioning

Barros, B. R., Schacht, A., Happich, M., Televantou, F., Berggren, L., Walker, D. J., & Dueñas, H. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.14m01661 · Cited by 2 · see citing works

Clinical staging and profiling of affective disorders

Beekman, A. T. F., Kupka, R., & van Exel, E. R. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02325-1 · Cited by 1 · see citing works

Impacts of Early Life Adversity on Microbiota and Immune Functioning in Individuals with Major Depressive Disorder

Richards, C. (2018) · doi:10.22215/etd/2018-13304 · Cited by 2 · see citing works

Clinical staging in depression

de la Fuente-Tomás, L., & García‐Portilla, M. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00026-8

Clinical Staging of Psychiatric Disorders: Its Utility in Mental Health Prevention

Rutigliano, G., & Grande, C. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-97906-5_2

TC18C MRI OF BRAIN VOLUMES AT THE PRODROME AND FIRST EPISODE STAGES OF SCHIZOPHRENIA

Perkins, D. O., Gu, H., Zipursky, R. B., Gerig, G., & Lieberman, J. A. (2006) · Schizophrenia Research · doi:10.1016/s0920-9964(06)70176-1

Illness history: Not associated with remission during treatment of major depression in 515 mood disorder patients

Baldessarini, R. J., Tondo, L., Visioli, C., & Vázquez, G. H. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.058 · Cited by 4 · see citing works

Number of episodes and antidepressant response in major depression

Joffe, R. T., Young, L. T., LEVITT, A. J., MacQUEEN, G. M., MARRIOTT, M. J., & Robb, J. C. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001443 · Cited by 10 · see citing works

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

Berk, M., Brnabic, A. J. M., Dodd, S., Kelin, K., Tohen, M. F., Malhi, G. S., Berk, L., Conus, P., & McGorry, P. D. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00889.x · Cited by 187 · see citing works

Illness Duration and Acute Response in Major Depression.

Black, D. W., Winokur, G., & Nasrallah, A. T. (1989) · PubMed · Cited by 16 · see citing works